Cargando…
Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment
With an estimated incidence of 490 000 cases in 2016, multidrug resistant tuberculosis (TB), against which key first-line anti-tuberculars are less efficacious, presents major challenges for global health. Poor treatment outcomes coupled with a yawning treatment gap between those in need of second-l...
Autores principales: | Koch, Anastasia, Cox, Helen, Mizrahi, Valerie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219890/ https://www.ncbi.nlm.nih.gov/pubmed/29885623 http://dx.doi.org/10.1016/j.coph.2018.05.013 |
Ejemplares similares
-
The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?
por: Koch, Anastasia, et al.
Publicado: (2014) -
The road to drug resistance in Mycobacterium tuberculosis
por: Koch, Anastasia, et al.
Publicado: (2014) -
Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment
por: Heidary, Mohsen, et al.
Publicado: (2022) -
Tuberculosis diagnostics: Challenges and opportunities
por: Nema, Vijay
Publicado: (2012) -
Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in Mycobacterium tuberculosis: Challenges and Opportunities
por: Sharma, Sandeep, et al.
Publicado: (2022)